GENERIC GLEEVEC: A COST-EFFECTIVE ALTERNATIVE?

The emergence of off-brand imatinib represents a substantial possibility for patients battling a certain type of cancer and other illnesses. Original brand-name imatinib, often referred to as Gleevec, carries a steep price tag, frequently causing accessibility for some individuals. Common version